A detailed history of Central Pacific Bank Trust Division transactions in Novo Nordisk A S stock. As of the latest transaction made, Central Pacific Bank Trust Division holds 6,172 shares of NVO stock, worth $524,620. This represents 0.09% of its overall portfolio holdings.

Number of Shares
6,172
Previous 12,791 51.75%
Holding current value
$524,620
Previous $1.83 Billion 59.75%
% of portfolio
0.09%
Previous 0.22%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 02, 2024

SELL
$119.07 - $145.42 $788,124 - $962,534
-6,619 Reduced 51.75%
6,172 $735 Million
Q2 2024

Jul 30, 2024

BUY
$122.71 - $146.91 $55,710 - $66,697
454 Added 3.68%
12,791 $1.83 Billion
Q1 2024

May 02, 2024

BUY
$102.11 - $135.92 $1.26 Million - $1.68 Million
12,337 New
12,337 $1.57 Billion

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $192B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Central Pacific Bank Trust Division Portfolio

Follow Central Pacific Bank Trust Division and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Central Pacific Bank Trust Division, based on Form 13F filings with the SEC.

News

Stay updated on Central Pacific Bank Trust Division with notifications on news.